Amundi’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Buy
14,775
+5,894
+66% +$190K ﹤0.01% 1666
2026
Q1
$218K Buy
+8,881
New +$211K ﹤0.01% 1850
2023
Q3
Sell
-22,934
Closed -$394K 2017
2023
Q2
$394K Sell
22,934
-29,720
-56% -$456K ﹤0.01% 1439
2023
Q1
$758K Sell
52,654
-66,455
-56% -$967K ﹤0.01% 1294
2022
Q4
$1.6M Buy
119,109
+6,916
+6% +$80.8K ﹤0.01% 1235
2022
Q3
$1.28M Buy
112,193
+39,457
+54% +$523K ﹤0.01% 1206
2022
Q2
$945K Buy
72,736
+7,464
+11% +$119K ﹤0.01% 1176
2022
Q1
$1.12M Sell
65,272
-4,221
-6% -$77K ﹤0.01% 1198
2021
Q4
$1.36M Buy
69,493
+11,743
+20% +$216K ﹤0.01% 1250
2021
Q3
$1.08M Buy
+57,750
New +$1.11M ﹤0.01% 1277

Other funds holding CSTM

Amundi's CSTM Position: Q2 2026 in Review

Amundi increased its Constellium (CSTM) stake by 66% in Q2 2026, buying an estimated $190K and bringing the position to 14,775 shares worth $471K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Amundi first reported a position in CSTM in Q3 2021 and has held it in 10 quarters since. The position peaked at $1.6M in Q4 2022. 388 funds tracked by Wall St. Rank hold CSTM as of Q2 2026.

  • Amundi held 14,775 shares of Constellium worth $471K as of Q2 2026.
  • Amundi bought 5,894 Constellium shares in Q2 2026, an estimated $190K.
  • Constellium made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1666 holding.
  • Amundi first reported a position in Constellium in Q3 2021 and has held it in 10 quarters since.
  • Amundi's Constellium position peaked at $1.6M in Q4 2022.
  • 388 funds tracked by Wall St. Rank held Constellium as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.